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Background/aim: To determine the roles of hepcidin and its related genes in a renal ischemia/reperfusion model.
Materials and methods: A total of 20 Wistar albino rats were equally divided into 2 groups: Group I was the control group and Group
II was the ischemia and reperfusion (I/R) group (60 min of ischemia + 48 h of reperfusion). I/R was performed on the left kidneys of
these rats and then the I/R-treated kidneys were removed. The levels of serum biochemical markers were evaluated after renal I/R. The
expression levels of hepcidin-linked genes [growth differentiation factor 15 (GDF-15), bone morphogenetic protein 6 (BMP6), and
hemojuvelin (HJV)] were also measured by RT-PCR technique. In addition, the tissues were evaluated histopathologically.
Results: No significant association was found between renal dysfunction and I/R when compared to biochemical parameters (P >
0.05). However, differences in platelet values were statistically significant (P < 0.05). Expression levels of GDF-15, BMP6, and HJV genes
increased, but this increase was not statistically significant. In addition, histopathological evaluation was performed using hematoxylin
and eosin stain. This showed a significant relationship between the control group and I/R group for ischemic and nonischemic kidney
scoring.
Conclusion: Hepcidin and BMP6, HJV, and GDF-15 should be taken into account when investigating the process of I/R.
Key words: Renal ischemia/reperfusion, hepcidin, BMP6, GDF-15, HJV

1. Introduction
Ischemia and reperfusion (I/R) injuries cause severe tissue
damage, and many researchers have focused on their
deteriorative effects. Previous studies have shown that
reactive oxygen species (ROS) play a critical role in I/R
injuries (1). ROS are produced within or outside of the cells
as a result of some cellular reactions. Iron is one important
factor that contributes to the production of ROS, due to its
interaction with other compounds. Specifically, nonlocalized
iron has an important role in the formation of ROS, which
occurs in Fenton and Haber–Weiss reactions and may cause
potentially deleterious effects in humans due to its redox
ability (2). Therefore, ROS can damage various cellular
macromolecules including lipids, DNA, carbohydrates, and
amino acids. This means that the iron levels in cells and
tissues must be regulated in order to prevent the ROS.
* Correspondence: drecepfatih@gmail.com
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Iron is essential for the growth and development of all
organisms and is of vital importance. Two-thirds of the iron
is used in the production of hemoglobin. The remaining iron
is used for myoglobin, respiratory enzymes, and hepatic
ferritin. It also plays an important role in the immune
system, energy production, RNA, DNA, and protein
synthesis because of its electron exchange features. Scarcity
or excess of iron in living organisms leads to many metabolic
disorders. Therefore, regulation of iron homeostasis
is very important. Previous studies have reported that
hepcidin is responsible for regulating iron homeostasis.
Hepcidin is an iron regulatory hormone that is produced
by many organs including the heart, kidney, and pancreas
(2–5). Serum iron levels and iron’s tissue distribution
are controlled by hepcidin. Moreover, it is known that
hemojuvelin (HJV), bone morphogenetic proteins
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(BMPs), and growth differentiation factor 15 (GDF-15)
are related to the expression of hepcidin (6,7). HJV, which
has an essential role in iron homeostasis, is a member of a
family of glycosylphosphatidylinositol-linked cell surface
proteins. HJV is a co-receptor for BMPs. It binds to various
forms of BMP to form a complex with BMP receptors. On
the other hand, GDF-15 suppresses expression of the iron
regulatory protein hepcidin (7).
The roles of diseases that cause I/R in the production
and metabolism of hepcidin are not understood.
Pathogenesis of renal I/R injury has been widely studied
due to its clinical importance and incidence. As a result of
I/R occurring in response to scarcity or excess of iron (iron
deficiency anemia, inflammation anemia and thalassemia,
hemochromatosis types), deterioration of blood flow,
physiopathological changes such as endothelial/epithelial
dysfunction in the kidneys, inflammation, and tubular
obstruction may develop. Although there are many studies
reporting the relationship between iron homeostasis and
hepcidin in I/R models such as myocardial (8) and liver (6)
models, there is no report on a renal I/R model. Therefore,
in the present study, we examined renal dysfunction,
injury, and serum biochemical markers (erythropoietin,
reticulocyte, iron, transferrin, hepcidin, and IL-6) in
the renal I/R model. The kidney tissues were evaluated
histopathologically. Expression levels of GDF-15, BMP6,
and HJV/HFE2 genes were also examined.
2. Materials and methods
2.1. Study groups
In this study, 20 male Wistar rats weighing 200 to 250 g
were used. The rats were put into a circadian rhythm with
the following conditions before the experiment: 24–26 °C
temperature and 50%–60% moisture rate. All experimental
protocols were approved by the Experimental Animal
Committee of Gaziantep University, Faculty of Medicine
(voucher number: 26.12.2011/57).
In Group I, the control group, none of the rats were
treated with any substance and they were not exposed to
I/R.
In Group II, the I/R group, none of the rats were treated
with any substance. Ischemia was performed to the right
renal artery and vein with a clamp during the 60 min after
laparotomy. After reperfusion of 48 h, all of the rats were
operated on for relaparotomy. The kidneys were removed
and blood samples were drawn. In the genetic analysis,
the left kidneys represented the I/R model and the right
kidneys represented the control group.
2.2. Laboratory measurements
2.2.1. Renal I/R model
All the rats were anesthetized with an intraperitoneal
injection of xylazine (10 mg/kg) and ketamine (40 mg/kg).
After anesthesia, the animal was fixed on the operating

table and the abdominal skin was shaved and sterilized with
70% ethyl alcohol. A midline incision was then made, and
the right renal artery was located and dissected free from its
surrounding structures. The right renal artery was clamped
for 60 min using a nontraumatic vascular clamp. The edges
of the abdominal incision were then brought together and
covered with a piece of gauze soaked with warm isotonic
saline to prevent undue loss of body fluids. After removal of
the vascular clamp on the right renal artery, the right kidney
was removed, and then the abdomen was properly irrigated
with isotonic saline. The abdominal incision was closed by
continuous stitches using 3/0 Vicryl sutures. Forty-eight
hours after ischemia, the animals were anesthetized with
ketamine/xylazine intraperitoneally (40/10 mg/kg), and
then kidney specimens were harvested.
2.2.2. Renal histopathological evaluation
After I/R, the kidneys were removed and placed in formalin.
Tissues were then embedded in paraffin according to the
standard protocol after alcohol and xylene treatments.
Samples of 5-µm sections were cut and stained with
hematoxylin and eosin and were visualized with a light
microscope.
Tissue samples were observed histopathologically
and scored as a result of semiquantitative evaluation. The
scoring was as follows: 0 = normal tissue; 1 = swollen
tubular epithelium cell areas, fewer than from 25% in cases
of necrosis; 2 = between 25% and 50% in similar cases; 3 =
between 50% and 75% in similar cases; 4 = between 75%
and 100% in similar cases.
2.2.3. RNA isolation and cDNA preparation
Total RNA samples were isolated using a modified method
by QIAGEN (Mainz, German). Total RNAs were reversetranscribed with a Roche AMV Reverse Transcription Kit
according to the procedures as provided by the supplier.
Briefly, 10X RT buffer (2.5 μL), MgCl2 (4 μL), dNTP (2.5
μL), random nonamer (5.25 μL), RNase inhibitor (0.5 μL),
AMV reverse transcriptase (0.5 μL), mRNA, and RNasefree water were mixed to obtain cDNA. The reaction
mixture was incubated at 45 °C for 45 min for reverse
transcription and heated at 94 °C for 2 min to inactivate
AMV reverse transcriptase. Obtained cDNAs were stored
at −20 °C until tested. cDNAs were then denatured at 94 °C
for 3 min; annealed at 59 °C for 45 s (BMP6), at 63 °C for 45
s (GDF-15), at 61 °C for 45 s (HJV), or at 59 °C for 45 s (betaactin); and extended at 72 °C for 30 s (all of them). PCR
mixtures (10 µL) were electrophoresed on 2% agarose gel,
which was subsequently stained with 0.5 µL/mL ethidium
bromide. Gels were scanned on an imaging analyzer and
the corresponding band densities were relatively measured.
At least 2 independent reverse transcriptase-polymerase
chain reaction (RT-PCR) analyses were performed. The
primer sequences used are given in Table 1.
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Table 1. Primer data of the targeted genes.
Genes
BMP6
GDF-15
HJV/HFE2

Primer

Sequence

Tm

Sense

5’-CGACACCACAAGGAGTTCAA-3’

58.0

Antisense

5’-ACCTCGCTCACCTTGAAGAA-3’

58.9

Sense

5’-CCCAGCTGTCCGGATACTC-3’

59.2

Antisense

5’-ATCATAAGTCTGCAGTGACA-3’

54.0

Sense

5’-CATGGCAGTCCTCCAACTCTA-3’

61.4

Antisense

5’-AGACGCAGGATTGGAAGTAGGC-3’

62.3

bp
407
628
1037

Tm: Melting temperature.

2.2.4. Quantitative RT-PCR
The mRNA expression levels of BMP6, GDF-15, and
HJV/HFE2 genes were analyzed by quantitative RT-PCR
technique using an Applied Biosystems GeneAmp PCR
System 9700 Thermal Cycler. The PCR products were run
on 3% agarose gel electrophoresis, stained with ethidium
bromide, and photographed after having been visualized
with an ultraviolet transilluminator.
2.2.5. Investigation of biochemical parameters
At the end of study, 2–3 mL of blood were transferred to
test tubes by intracardiac method. Samples were held at
room temperature for 30 min and then centrifuged at 4000
rpm for 10 min. The obtained blood serum was stored at
–80 °C until tested. The whole blood and reticulocyte and
the iron (Fe) values were then determined with equipment
from Beckman Coulter (LH780EPO) and Architech
(c16000), respectively. The levels of erythropoietin (EPO),
interleukin-6 (IL-6), and soluble transferrin receptor (sTfR)
(R&D Systems Europe, Ltd., UK.) were determined by
sandwich enzyme-linked immunosorbent assay (ELISA).
Transferrin (Assaypro LLC, St Charles, MO, USA) and
hepcidin (EIAab Science Co., Ltd., Wuhan, China) were
determined by quantitative immunoassay method with an
ELx 800 (BioTek Inc., Winooski, VT, USA).
2.3. Statistical analysis
All values are reported as mean ± standard deviation.
Statistical analysis for gene expression and biochemical
parameters was carried out by nonparametric Wilcoxon
test using the program GraphPad Prism 5 (GraphPad
Software, San Diego, CA, USA) and the Mann–Whitney U
test, respectively. For comparison, the left kidney was used
as an internal control. P < 0.05 was considered significant.
3. Results
In this study, a total of 20 rats were used for control and
I/R groups. The expression levels of BMP6, GDF-15, and
HJV genes were measured. Blood samples were also tested
for hemoglobin (Hb), red blood cell (RBC), platelet, iron,
reticulocyte percentage (Ret %), transferrin (TfR), sTfR,
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EPO, IL-6, and hepcidin levels. In addition to these
results, kidney tissues were scored histopathologically.
3.1. Histopathological evaluation
The kidney tissues were observed by light microscope
according to standard procedures. Histopathological
evaluation of tissues was as follows: 0 = normal tissue;
1 = swollen tubular epithelium cell areas, fewer than
25% in cases of necrosis; 2 = between 25% and 50% in
similar cases; 3 = between 50% and 75% in similar cases;
4 = between 75% and 100% in similar cases according to
previous studies applied in a renal I/R model.
Light microscope pictures of the control, nonischemic
right kidney and I/R kidneys are showed in Figures
1A–1D. I/R kidney tissues were more deteriorated
than nonischemic and control tissues. Swollen tubular
epithelium cell areas, vacuolar deterioration, intercellular
cast formations (“), and necrosis in the I/R group were
determined to be average in tissues with a score of 3.
Moreover, swollen tubular epithelium cell areas, vacuolar
deterioration, and necrosis were lower than 25% for
nonischemic kidneys.
3.2. Gene expressions analysis
Expression levels of BMP6, GDF-15, and HJV genes were
measured by using the RT-PCR method.
As shown in Table 2, the expression of BMP6, GDF-15,
and HJV genes increased in the I/R group. The expression
levels of these genes were statistically insignificant in the
ischemic group compared to the nonischemic group (P
> 0.05).
3.3. Biochemical parameters
As can be seen in Table 3, hepcidin, transferrin, IL-6,
EPO, and thrombocyte levels were increased and Hb,
sTfR, erythrocyte, and reticulocyte levels were decreased
with I/R treatment when compared to the control group.
Taken together, the relationship between these increases
and decreases was not statistically significant (P >
0.05). There was only a statistically significant positive
relationship in the increase of thrombocyte levels (P <
0.05).
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Figure 1. Histological analysis of renal tissue with hematoxylin and eosin staining. A and B: nonischemic right kidney; C and
D: ischemic left kidney.

4. Discussion
I/R causes serious tissue disorders in many organs,
including the heart, muscle, liver, lungs, and kidneys. In
the renal system, a reduction in or stoppage of the blood
flow is the main reason for cell damage.
Tubular injury, tubular cell necrosis, and tubular
dysfunction in kidney tissues have been reported

in various I/R models (1,9,10). In the present study,
extravasation, tubular structures, loss of the nucleus
in tubular epithelial cells, tubular dilation, interstitial
lymphocyte accumulation, and tubular necrosis were
determined by using the scoring method in ischemic and
nonischemic groups. As shown in Table 4, the kidney
tissue damage increased in the I/R group when compared

Table 2. Results of targeted gene expressions.

Table 3. Biochemical results of the rat blood.

Genes
BMP6

GDF-15

HJV

Groups

Expression

SD (±)

Nonischemic

0.257

0.209

IR

0.37

0.317

Nonischemic

0.42

0.379

IR

0.66

0.202

Nonischemic

0.406

0.266

IR

0.454

0.227

P
P > 0.05

P > 0.05

P > 0.05

Compounds

Control

IR

P

Hepcidin

139.5

167.2

P > 0.05

Transferrin

0.985

1.045

P > 0.05

IL-6

6.169

7.432

P > 0.05

Erythropoietin

102.4

111.5

P > 0.05

Platelets

549.1

749.2

P < 0.05

Hemoglobin

130.5

118.1

P > 0.05

sTfR

6.36

6.25

P > 0.05

Erythrocytes

6.92

6.87

P > 0.05

Reticulocytes

4.27

3.83

P > 0.05
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Table 4. Histopathological scores of ischemic and nonischemic
groups.
Control

I/R nonischemic
right kidney

I/R ischemic
left kidney

1.

0

1

3

2.

0

2

4

3.

0

2

4

4.

0

2

4

5.

0

2

4

6.

0

2

4

7.

0

1

3

8.

0

1

3

9.

0

1

3

10.

0

1

3

P

0 ± 0.0

1.5 ± 0.1

3.5 ± 0.1

to the control. Chiang et al. (10) reported that MDA levels
in renal tissue increased due to an increase of oxidative
stress and H2O2 after I/R. The increase is an indicator of
structural deterioration since oxidative stress and H2O2
were the causes of the damaged tissues in the I/R group.
Deteriorated structures in nonischemic right kidney
tissues were also observed. It has been reported that other
organs are affected in cases of renal I/R injury. As a result,
the present study shows that the right kidney, which was
not exposed to I/R, was damaged when compared to the
control. Therefore, I/R may affect other organs or tissues.
Our findings showed that the hepcidin level increased
after approximately 48 h of reperfusion. Since the increase
of hepcidin prevents uptake and release of iron, the level
of iron decreased in the serum. It is known that iron is
essential for erythropoietic activity and Hb formation
(11), and, therefore, a deficiency of iron may reduce the
levels of RBCs, Hb, and Ret %. The level of sTfR may also
be reduced due to the decreasing erythroid proliferation
in serum. When iron levels are reduced in the serum, the
level of TfR increases for more uptake of iron (12,13).
In the results of the present study, TfR level increased in
serum. Moreover, levels of IL-6 and EPO may be increased
due to hypoxia and inflammation in the process of I/R.

EPO is a hormone produced in the liver and kidneys. In
order to meet the organs’ needs, EPO suppresses hepcidin
expression when production of EPO increases in the
liver and kidneys. However, the suppression mechanism
has not been clarified yet. In addition, the platelet level
increased, and this was found to be statistically significant.
This increase is probably due to platelet-derived growth
factor secreted by renal tubular cells to repair damage in
the kidneys after reperfusion.
Hepcidin synthesis and expression of the BM-6 gene
increased in the I/R group. Wang et al. (14) reported that
BMP6 reduces ischemia-induced brain damage due to
its prevention of H2O2 activity. It has been reported that
BMP6 protects renal proximal tubule cells (HK-2) against
H2O2 in the kidney (15). Despite these reports, the effect of
BMP6 expression in the kidney has yet to be documented
exactly. Moreover, expression of HJV, which is a coreceptor of BMP6 (16,17), also increased. It is known that
HJV regulates the hepcidin expression and blood iron
homeostasis via BMP signaling (6). As a result, BMP6 and
HJV gene products have an important role in protecting
tissue after I/R. In addition to BMP and HJV, expression
of GDF-15 also increased. The increased expression of
GDF-15 may be associated with hepcidin synthesis and
Fe homeostasis; however, the mechanism still remains
unclear.
In conclusion, there is severe tissue damage after I/R.
The present study shows that the most severe effects were
observed histopathologically in the I/R group. On the
other hand, levels of hepcidin and expression of its related
genes increased in the I/R group; however, the increase
was insignificant statistically. While levels of TfR, IL-6,
EPO, platelets, and Hb increased in the I/R group, those of
sTfR, erythrocytes, and reticulocytes reduced. Moreover,
only the increase in the level of platelets was significant
statistically. Consequently, although they were insignificant
statistically, it can be said that both hepcidin and the BMP6,
HJV, and GDF-15 genes may have important roles in I/R.
To better understand these roles, it is suggested that the
protein levels of these genes be determined by western blot
method in further studies. Our study can be considered as
the first detailed document on the level of hepcidin and
expressions of BMP6, HJV, and GDF-15 genes in a renal
ischemia reperfusion model.
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